**Subject:** Collaboration on Diversity Initiative in Clinical Trials

---

**From:** Don Snow <dmadden@example.org>  
**To:** Bailey Pitts <michaela55@example.org>  
**Date:** October 10, 2023  

Hi Bailey,

I hope this message finds you well. I'm reaching out to discuss the upcoming diversity initiative we are planning to implement in the clinical trials for our new oncology drug, currently under the project name "Project Phoenix."

Given your expertise in diversity and inclusion, I believe your input would be invaluable in ensuring we have a representative participant demographic. We're particularly focused on enhancing outreach to underrepresented communities, and I think a strategic approach could significantly improve our recruitment process.

Could we schedule a meeting to discuss this further? I am available for a call this Thursday after 2 PM or at your convenience. Please let me know your schedule, and we can coordinate.

Looking forward to collaborating with you on this important aspect of our project.

Best regards,  
Don Snow  
Clinical Biochemist | Merck  
Phone: (908) 555-0198

---

**From:** Bailey Pitts <michaela55@example.org>  
**To:** Don Snow <dmadden@example.org>  
**Date:** October 11, 2023  

Hi Don,

Thank you for reaching out. I'm really excited about Project Phoenix and the potential impact it could have. Ensuring diversity in clinical trials is crucial, and I'm glad we're prioritizing this.

I'm available for a call on Thursday at 3 PM. Does that work for you? We can discuss strategies to engage with diverse communities and possibly involve some local advocacy groups that have been successful in similar initiatives.

Also, as a heads-up, I'll be out of the office for a conference from October 16-20, so it would be great to get as much planned as possible before then. We can follow up with any action items once I'm back.

Looking forward to our discussion.

Best,  
Bailey Pitts  
Equality and Diversity Officer | Merck  
Office: Building 3, Room 204  
Phone: (908) 555-0234